This novel medication works by enhancing insulin secretion in a glucose-dependent manner, suppressing glucagon release, slowing gastric emptying, and reducing appetite through central nervous system pathways
It is a non-invasive method of treatment, painless to the subject, and easy to administer
Gingivitis can progress to periodontitis, with bone loss around teeth, in a fraction of the time it would take with normal saliva flow
Many people feel less bloated within 2 to 4 weeks
Pay special attention to areas where skin folds or moisture can be trapped, like underarms, the groin area, and under the breasts
Its what's known as a triple agonist, targeting three different receptors: the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and the glucagon receptor (GCG)